CELL SIGNALING TECHNOLOGY search Cell Signaling Technology JUN products
includes other brands or spellings
|
| elisa | | Cell Signaling Technology Phospho-c-Jun (Ser-63) Sandwich ELISA kit was used in human MCF-7 cells to assess c-Jun phosphorylation. |
| emsa | | New England Biolabs anti-phospho-c-Jun (Ser-63) antibody was used in EMSA to study the effect of serine protease plasmin on expression of MCP-1 and CD40 in human primary monocytes. |
| ic, ih | | New England Biolabs anti-c-jun and anti-phospho-c-jun (Ser63) antibodies were used in immunohistochemistry and immunocytochemistry to study 3-NP-induced striatal neurodegeneration. |
| ic | | Cell Signaling anti-human phospho-c-Jun antibody was used in immunocytochemistry to detect phospho-c-Jun in schwann and schwannoma cells. |
| ih | | Cell Signaling anti-phospho-c-Jun antibody was used in immunohistochemistry to study that transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. |
| wb | | Cell Signaling anti-phospho-c-Jun (catalog no. 9261; phosphoserine 63) antibody was used in western blot to study tumor necrosis factor alpha-dependent drug resistance to purine and pyrimidine analogues in human colon tumor cells. |
| wb | | New England Biolabs rabbit polyclonal antibody which recognizes phospho-c-Jun (Ser73) was used in western blot to study the role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. |
| wb | | Cell Signaling antibody against phospho-c-Jun was used in western blot to study the interaction of the down syndrome cell adhesion molecule (DSCAM) with Pak. |
| wb | | New England Biolabs anti-c-Jun and anti-phosphoJun polyclonal antibodies were used in western blot to further elucidate the activation mechanism for intracellular signaling mediated by interaction between Dok1 and phosphorylated RET. |
| wb | | Cell Signaling Technology anti-c-Jun and anti-p-c-Jun antibodies were used in western blot to study the effect of coagulation factor Xa and TNF on tissue factor. |
| wb | | Cell Signaling Technology antibody against phospho-c-Jun (Ser63) was used in western blot to study the role of JNK in contributing to the synergistic effect of TRAIL plus DNA damage by mediating signals independent of p53 leading to apoptosis in chemoresistant mesothelioma cells. |
| wb | | Cell Signaling Technology anti-human phospho-c-Jun (Ser63) antibody was used in western blot to detect Phospho-c-Jun in PC12 cell lines transfected with DNA constructs harboring human wild-type APP (APPwt) or mutant APPsw gene. |
| wb | | Cell Signaling Technology anti-Jun and phospho-Jun antibody was used in western blot to detect Jun and phospho-Jun in HEK 293 cells transfected with various combinations of JIP-1, JNK, and MLK3. |
| wb | | Cell Signaling Technology anti-c-Jun and phospho-c-Jun antibody was used in western blot to detect c-Jun and phospho-c-Jun in cortical neurons, U373 and PC12 cells infected with LacZ or p75NTR recombinant adenovirus. |
| wb | | Cell Signaling Technology anti-phospho-c-Jun antibody was used in western blot to detect phospho-c-Jun in human peripheral T lymphocytes. |
| wb | | New England Biolabs antibodies against c-Jun and phospho-c-Jun (Ser-63) II was used in western blot to examine total c-Jun and phospho-c-Jun levels, respectively, in human HEK 293 cells. |
| wb | | Cell Signaling anti-c-Jun (Ser-63) antibody (catalog number 9261) was used in human LNCaP cells and in western blot to study the role of epidermal growth factor in transforming growth factor beta signaling and growth suppression. |
| wb | | Cell Signaling Technology anti-c-JUN and anti-phospho-c-JUN (Ser73) antibodies were used in human 1HAEo cell line and in western blot to study the link between the PI3K-Akt pathway and the cigarette smoke (CS) -stimulated epidermal growth factor receptor-mediated FRA-1 induction in non-oncogenic HBE cells. |
| wb | | Cell Signaling Technology c-Jun Ser73 antibody was used in western blot to study VEGF mRNA stability in DU145 prostate carcinoma. |
| wb | | Cell Signaling phospho-c-Jun antibody was used in western blot to investigate regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. |
| wb | | Cell Signaling anti-c-Jun and anti-phospho-c-Jun antibodies were used in western blot to study the interaction of Sef with TAK1 which mediates JNK activation and apoptosis. |
| wb | | New England Biolabs anti-phospho-cJun antibody was used in western blot to study the role for the innate immune signaling molecule IRAK-4 in T cell
activation. |
EPITOMICS search Epitomics JUN products
|
| ih | | Epitomics JUN antibody was tested in immunohistochemistry by HPA (CAB003801) . |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology JUN products
includes other brands or spellings
|
| emsa, wb | | Santa Cruz Biotechnology anti-c-Jun antibody (SC1694) was used in western blot and EMSA to study composition and function of AP-1 transcription complexes during muscle cell differentiation. |
| emsa | | Santa Cruz Biotechnology c-Jun antibody was used in EMSA to study RANTES expression regulation by plasma membrane CFTR. |
| emsa | | Santa Cruz Biotechnology anti-c-Jun antibody was used in EMSA to identify a human NF-kappaB-activating protein designated TAK1-binding protein 3 (TAB3). |
| emsa | | Santa Cruz Biotechnology polyclonal anti-c-Jun antibody was used in EMSA to study that induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun. |
| emsa | | Santa Cruz Biotechnology polyclonal anti-AP1 antibody was used in EMSA to study the role of EPAS1 in the hypoxia-induced expression of the PAI-1 gene. |
| emsa | | Santa Cruz Biotechnology anti-AP1 antibody was used in human pancreatic carcinoma-derived cell line Panc-1 and normal human keratinocyte cell line HaCaT and in EMSA to study the effect of the interaction of RhoB, Not RhoA with activator protein 1 on transcription of the transforming growth factor beta type II receptor. |
| emsa | | Santa Cruz polyclonal anti-c-jun antibody was used in EMSA to study AP-1 DNA binding activity in human DLD-1 cells. |
| ih | | Santa Cruz Biotechnology primary rabbit polyclonal anti-c-Jun antibody was used in immunohistochemistry to study the expression of the AP-1 transcription factors (c-jun, junD, junB, and c-fos) and the marginal zone B-cell transcription factor notch2 in splenic marginal zone lymphoma. |
| ip, wb | | Santa Cruz Biotechnology monoclonal phospho-c-Jun (KM-1) antibody and polyclonal c-Jun (H-79) antibody were used in western blot and immunoprecipitation to study the effect of Wnt-7a in corneal epithelial cells during wound healing. |
| wb | | Santa Cruz Biotechnology rabbit polyclonal antibody which recognizes Phospho-JNK2 (p54) was used in western blot to study the role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. |
| wb | | Santa Cruz Biotechnology anti-C-jun polyclonal antibody was used in western blot to study the insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2. |
| wb | | Santa Cruz Biotechnology anti-c-Jun antibody was used in western blot to detect c-Jun in human peripheral T lymphocytes. |
| wb | | Santa Cruz Biotechnology anti-pJUN antibody (sc-822) was used in human HepG2 cells and in western blot to study the effect of inhibitor κB kinase complex on insulin receptor substrate 1. |
| wb | | Santa Cruz Biotechnology anti-c-Jun and phosphorylated c-Jun antibody was used in western blot to detect c-Jun and phosphorylated c-Jun in HepG2 cells expressing CYP2E1 or CYP3A4. |
| wb | | Santa Cruz Biotechnology anti-c-JUN antibody (SC-45X) was used in human 1HAEo cell line and in western blot to study the link between the PI3K-Akt pathway and the cigarette smoke (CS) -stimulated epidermal growth factor receptor-mediated FRA-1 induction in non-oncogenic HBE cells. |
| wb | | Santa Cruz Biotechnology anti-c-Jun antibody was used in western blot to study the dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. |
| wb | | Santa Cruz Biotechnology c-Jun rabbit polyclonal antibody was used in western blot to study the inhibition of matrix metalloproteinase-9 expression by ascochlorin. |
BD BIOSCIENCES search BD Biosciences JUN products
includes other brands or spellings
|
| wb | | BD Transduction Jun antibody was tested in western blot by Abminer. |
| wb | | Transduction Laboratories antibody against c-Jun was used in western blot to study the role for AP-1 in the induction of Smad7 expression by UV irradiation in human skin fibroblasts. |
| wb | | Transduction Laboratories monoclonal anti-c-Jun antibody was used in western blot to study that induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun. |
EMD BIOSCIENCES search EMD Biosciences JUN products
includes other brands or spellings
|
| ip | | Oncogene anti-Jun antibody was used in immunoprecipitation to develop a cell-free cotranslation and selection method. |
| wb | | Calbiochem rabbit polyclonal anti-human c-Jun antibody was used in western blot to detect c-Jun in normal and tumoral schwann cells. |
| wb | | Calbiochem mouse anti-c-jun/AP-1 antibody and rabbit anti-c-jun phospho-specific Ser73 were used in western blot to study 7-Kchol induces oxidative stress and apoptotic events in human aortic smooth muscle cells. |
MILLIPORE search Millipore JUN products
includes other brands or spellings
|
| wb | | Upstate Biotechnology anti-c-Jun antibody was used in western blot to detect c-Jun in both air and hypoxic A549 cells. |
| wb | | Upstate Biotechnology anti-c-Jun antibody and anti-phospho-Jun (Ser73) antibody were used in human PC-3 cells and in western blot to study the difference between SENP1 and SENP2 in the regulation of c-Jun-dependent transcription. |
ACTIVE MOTIF search Active Motif JUN products
includes other brands or spellings
|
| emsa | | Geneka/Active Motif rabbit antibody against c-Jun was used in EMSA to study the regulation of human 3' Igh hs4 enhancer activity in B cells by synergistic interaction between Oct-2 and NF-kappaB. |
Articles Reviewed |
| 1. Jalila Adnane et al. RhoB, not RhoA, represses the transcription of the transforming growth factor beta type II receptor by a mechanism involving activator protein 1. 2002 |
| 2. John J Andreucci et al. Composition and function of AP-1 transcription complexes during muscle cell differentiation. 2002 |
| 3. Marta Garcia et al. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module. 2002 |
| 4. Hideki Murakami et al. Role of Dok1 in cell signaling mediated by RET tyrosine kinase. 2002 |
| 5. Ladislav Burysek et al. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. 2002 |
| 6. Markus Hellmuth et al. Expression of interleukin-8, heme oxygenase-1 and vascular endothelial growth factor in DLD-1 colon carcinoma cells exposed to pyrrolidine dithiocarbamate. 2002 |
| 7. Zhanguo Gao et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. 2002 |
| 8. Elizabeth K Brint et al. Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction. 2002 |
| 9. Monique C A Duyndam et al. Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. 2003 |
| 10. Kim Estell et al. Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif. 2003 |
| 11. Hongzhi Sun et al. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2. 2003 |
| 12. Dirk Haller et al. Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. 2003 |
| 13. Claire Vivo et al. c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells. 2003 |
| 14. Celio A Marques et al. Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. 2003 |
| 15. Yu-Long Hu et al. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. 2003 |
| 16. Katherine Kaempchen et al. Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells. 2003 |
| 17. Pengfei Gong et al. Increased expression of cytochrome P450 2E1 induces heme oxygenase-1 through ERK MAPK pathway. 2003 |
| 18. Meir H Scheinfeld et al. Amyloid beta protein precursor is phosphorylated by JNK-1 independent of, yet facilitated by, JNK-interacting protein (JIP)-1. 2003 |
| 19. Ying-Nai Wang et al. Induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun. 2003 |
| 20. Charles S Powell et al. p38mapk and MEK1/2 inhibition contribute to cellular oxidant injury after hypoxia. 2004 |
| 21. Asha L Bhakar et al. Apoptosis induced by p75NTR overexpression requires Jun kinase-dependent phosphorylation of Bad. 2003 |
| 22. Manuel A Sepulveda et al. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. 2004 |
| 23. Ge Jin et al. Identification of a human NF-kappaB-activating protein, TAB3. 2004 |
| 24. Mahito Sato et al. The PAI-1 gene as a direct target of endothelial PAS domain protein-1 in adenocarcinoma A549 cells. 2004 |
| 25. Weiquan Li et al. The Down syndrome cell adhesion molecule (DSCAM) interacts with and activates Pak. 2004 |
| 26. Xuehui Yang et al. Sef interacts with TAK1 and mediates JNK activation and apoptosis. 2004 |
| 27. Ivan Mattioli et al. Comparative analysis of T-cell costimulation and CD43 activation reveals novel signaling pathways and target genes. 2004 |
| 28. Gunhild Trøen et al. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. 2004 |
| 29. Eric Pedruzzi et al. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. 2004 |
| 30. Taihao Quan et al. Ultraviolet irradiation induces Smad7 via induction of transcription factor AP-1 in human skin fibroblasts. 2005 |
| 31. Ling-Chi Wang et al. Tumor necrosis factor alpha-dependent drug resistance to purine and pyrimidine analogues in human colon tumor cells mediated through IKK. 2005 |
| 32. Hee Yun et al. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. 2005 |
| 33. Jinke Cheng et al. Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases. 2005 |
| 34. Jungmook Lyu et al. Wnt-7a up-regulates matrix metalloproteinase-12 expression and promotes cell proliferation in corneal epithelial cells during wound healing. 2005 |
| 35. SaHyun Hong et al. Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. 2005 |
| 36. Etsuko Miyamoto-Sato et al. Cell-free cotranslation and selection using in vitro virus for high-throughput analysis of protein-protein interactions and complexes. 2005 |
| 37. Guillaume Bossis et al. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. 2005 |
| 38. Ayala Hezi-Yamit et al. Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascades. 2005 |
| 39. Kyung Song et al. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II. 2006 |
| 40. Qin Zhang et al. A Phosphatidylinositol 3-kinase-regulated Akt-independent signaling promotes cigarette smoke-induced FRA-1 expression. 2006 |
| 41. T Pukrop et al. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. 2006 |
| 42. Nobutaka Suzuki et al. A critical role for the innate immune signaling molecule IRAK-4 in T cell activation. 2006 |
| 43. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 44. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |